Global NGS Informatics and Clinical Genomics 麻豆原创 Research Report 2024

Publication ID:

PB505249982

Publication Date:

May 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Clinical informatics tools enable the translation of next-generation sequencing and array data into clinically meaningful information.
The global NGS Informatics and Clinical Genomics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for NGS Informatics and Clinical Genomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for NGS Informatics and Clinical Genomics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for NGS Informatics and Clinical Genomics in Academics and Research Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of NGS Informatics and Clinical Genomics include 2bPrecise, Epic Systems, Flatiron Health, GenomOncology, Illumina, IBM, Koninklijke Philips, QIAGEN and SOPHiA GENETICS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for NGS Informatics and Clinical Genomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGS Informatics and Clinical Genomics.
Report Scope
The NGS Informatics and Clinical Genomics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NGS Informatics and Clinical Genomics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the NGS Informatics and Clinical Genomics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
2bPrecise
Epic Systems
Flatiron Health
GenomOncology
Illumina
IBM
Koninklijke Philips
QIAGEN
SOPHiA GENETICS
Segment by Type
LIMS
Data Analysis
Interpretation Tools
Storage
Computing Solutions
Segment by Application
Academics and Research Institutes
Biopharmaceutical Industry
Diagnostic Industry
Government Agencies
Hospitals and Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NGS Informatics and Clinical Genomics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global NGS Informatics and Clinical Genomics 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 LIMS
1.2.3 Data Analysis
1.2.4 Interpretation Tools
1.2.5 Storage
1.2.6 Computing Solutions
1.3 麻豆原创 by Application
1.3.1 Global NGS Informatics and Clinical Genomics 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academics and Research Institutes
1.3.3 Biopharmaceutical Industry
1.3.4 Diagnostic Industry
1.3.5 Government Agencies
1.3.6 Hospitals and Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS Informatics and Clinical Genomics 麻豆原创 Perspective (2019-2030)
2.2 NGS Informatics and Clinical Genomics Growth Trends by Region
2.2.1 Global NGS Informatics and Clinical Genomics 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 NGS Informatics and Clinical Genomics Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 NGS Informatics and Clinical Genomics Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 NGS Informatics and Clinical Genomics 麻豆原创 Dynamics
2.3.1 NGS Informatics and Clinical Genomics Industry Trends
2.3.2 NGS Informatics and Clinical Genomics 麻豆原创 Drivers
2.3.3 NGS Informatics and Clinical Genomics 麻豆原创 Challenges
2.3.4 NGS Informatics and Clinical Genomics 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS Informatics and Clinical Genomics Players by Revenue
3.1.1 Global Top NGS Informatics and Clinical Genomics Players by Revenue (2019-2024)
3.1.2 Global NGS Informatics and Clinical Genomics Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global NGS Informatics and Clinical Genomics 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NGS Informatics and Clinical Genomics Revenue
3.4 Global NGS Informatics and Clinical Genomics 麻豆原创 Concentration Ratio
3.4.1 Global NGS Informatics and Clinical Genomics 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS Informatics and Clinical Genomics Revenue in 2023
3.5 NGS Informatics and Clinical Genomics Key Players Head office and Area Served
3.6 Key Players NGS Informatics and Clinical Genomics Product Solution and Service
3.7 Date of Enter into NGS Informatics and Clinical Genomics 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS Informatics and Clinical Genomics Breakdown Data by Type
4.1 Global NGS Informatics and Clinical Genomics Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global NGS Informatics and Clinical Genomics Forecasted 麻豆原创 Size by Type (2025-2030)
5 NGS Informatics and Clinical Genomics Breakdown Data by Application
5.1 Global NGS Informatics and Clinical Genomics Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global NGS Informatics and Clinical Genomics Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America NGS Informatics and Clinical Genomics 麻豆原创 Size (2019-2030)
6.2 North America NGS Informatics and Clinical Genomics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America NGS Informatics and Clinical Genomics 麻豆原创 Size by Country (2019-2024)
6.4 North America NGS Informatics and Clinical Genomics 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NGS Informatics and Clinical Genomics 麻豆原创 Size (2019-2030)
7.2 Europe NGS Informatics and Clinical Genomics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe NGS Informatics and Clinical Genomics 麻豆原创 Size by Country (2019-2024)
7.4 Europe NGS Informatics and Clinical Genomics 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS Informatics and Clinical Genomics 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific NGS Informatics and Clinical Genomics 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific NGS Informatics and Clinical Genomics 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific NGS Informatics and Clinical Genomics 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NGS Informatics and Clinical Genomics 麻豆原创 Size (2019-2030)
9.2 Latin America NGS Informatics and Clinical Genomics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America NGS Informatics and Clinical Genomics 麻豆原创 Size by Country (2019-2024)
9.4 Latin America NGS Informatics and Clinical Genomics 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS Informatics and Clinical Genomics 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa NGS Informatics and Clinical Genomics 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa NGS Informatics and Clinical Genomics 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa NGS Informatics and Clinical Genomics 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 2bPrecise
11.1.1 2bPrecise Company Detail
11.1.2 2bPrecise Business Overview
11.1.3 2bPrecise NGS Informatics and Clinical Genomics Introduction
11.1.4 2bPrecise Revenue in NGS Informatics and Clinical Genomics Business (2019-2024)
11.1.5 2bPrecise Recent Development
11.2 Epic Systems
11.2.1 Epic Systems Company Detail
11.2.2 Epic Systems Business Overview
11.2.3 Epic Systems NGS Informatics and Clinical Genomics Introduction
11.2.4 Epic Systems Revenue in NGS Informatics and Clinical Genomics Business (2019-2024)
11.2.5 Epic Systems Recent Development
11.3 Flatiron Health
11.3.1 Flatiron Health Company Detail
11.3.2 Flatiron Health Business Overview
11.3.3 Flatiron Health NGS Informatics and Clinical Genomics Introduction
11.3.4 Flatiron Health Revenue in NGS Informatics and Clinical Genomics Business (2019-2024)
11.3.5 Flatiron Health Recent Development
11.4 GenomOncology
11.4.1 GenomOncology Company Detail
11.4.2 GenomOncology Business Overview
11.4.3 GenomOncology NGS Informatics and Clinical Genomics Introduction
11.4.4 GenomOncology Revenue in NGS Informatics and Clinical Genomics Business (2019-2024)
11.4.5 GenomOncology Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina NGS Informatics and Clinical Genomics Introduction
11.5.4 Illumina Revenue in NGS Informatics and Clinical Genomics Business (2019-2024)
11.5.5 Illumina Recent Development
11.6 IBM
11.6.1 IBM Company Detail
11.6.2 IBM Business Overview
11.6.3 IBM NGS Informatics and Clinical Genomics Introduction
11.6.4 IBM Revenue in NGS Informatics and Clinical Genomics Business (2019-2024)
11.6.5 IBM Recent Development
11.7 Koninklijke Philips
11.7.1 Koninklijke Philips Company Detail
11.7.2 Koninklijke Philips Business Overview
11.7.3 Koninklijke Philips NGS Informatics and Clinical Genomics Introduction
11.7.4 Koninklijke Philips Revenue in NGS Informatics and Clinical Genomics Business (2019-2024)
11.7.5 Koninklijke Philips Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Detail
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN NGS Informatics and Clinical Genomics Introduction
11.8.4 QIAGEN Revenue in NGS Informatics and Clinical Genomics Business (2019-2024)
11.8.5 QIAGEN Recent Development
11.9 SOPHiA GENETICS
11.9.1 SOPHiA GENETICS Company Detail
11.9.2 SOPHiA GENETICS Business Overview
11.9.3 SOPHiA GENETICS NGS Informatics and Clinical Genomics Introduction
11.9.4 SOPHiA GENETICS Revenue in NGS Informatics and Clinical Genomics Business (2019-2024)
11.9.5 SOPHiA GENETICS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

2bPrecise
Epic Systems
Flatiron Health
GenomOncology
Illumina
IBM
Koninklijke Philips
QIAGEN
SOPHiA GENETICS

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.